Sewon Corporation Co.,Ltd. (KOSDAQ:024830)

Revance Therapeutics Revenue

Sewon Corporation had revenue of 45.46B KRW in the quarter ending March 31, 2025, with 8.09% growth. This brings the company's revenue in the last twelve months to 234.31B, up 26.55% year-over-year. In the year 2024, Sewon Corporation had annual revenue of 230.91B with 19.61% growth.

• Revenue (ttm): 234.31B
• Revenue Growth: +26.55%
• P/S Ratio: 0.39
• Revenue / Employee: 532.52M
• Employees: 440
• Market Cap: 90.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	230.91B	37.86B	19.61%
Dec 31, 2023	193.04B	21.91B	12.80%
Dec 31, 2022	171.13B	-38.96B	-18.54%
Dec 31, 2021	210.09B	54.05B	34.64%
Dec 31, 2020	156.04B	40.76B	35.36%